Technology
Health
Pharmaceutical

MediWound

$3.71
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.30 (8.80%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell MediWound and other stocks, options, ETFs, and crypto commission-free!

About MDWD

MediWound Ltd. Ordinary Shares, also called MediWound, is a biopharmaceutical company, which engages in the development, manufacture and commercialization of novel products to address needs in the fields of severe burn; chronic and other hard-to-heal wounds; and connective tissue disorders. Read More Its medicinal product, NexoBrid, is used to remove eschar in adults patients with deep partial- and full-thickness thermal burns. The company was founded by Lior Rosenberg and Marian Gorecki on January 27, 2000 and is headquartered in Yavne, Israel.

Employees
73
Headquarters
Yavne, HaMerkaz
Founded
2000
Market Cap
100.83M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
43.92K
High Today
$3.82
Low Today
$3.43
Open Price
$3.43
Volume
101.95K
52 Week High
$6.75
52 Week Low
$3.00

Collections

Technology
Health
Pharmaceutical
Biopharmaceutical
2014 IPO
Asia (Non-China)
Asia
Female CEOs

MDWD Earnings

-$0.20
-$0.15
-$0.10
-$0.05
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 7, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.